Antonio Covarrubias, MD
Vascular Surgery · Newport Beach, CANPI 1679834907
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 46.3% of the total. Reporting peaked in 2022 at $40,770 and has fallen 84.5% since, to $6,299 in 2025. Among vascular surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 371 payments — averaging $208.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$36K
- Endologix LLC$18K
- Medtronic$12K
- Silk Road Medical, Inc.$2K
- Penumbra, Inc.$1K
- Shockwave Medical, Inc$1K
- plus $7K from 28 others
What the payments were for
- Consulting fees$46,10060%
- Travel & lodging$11,55515%
- Food & beverage$19,60425%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 41 | $35,800 |
| Endologix LLC | 69 | $18,132 |
| Medtronic(2 entities) | 61 | $11,997 |
| Silk Road Medical, Inc. | 26 | $2,000 |
| Penumbra, Inc. | 8 | $1,484 |
| Shockwave Medical, Inc | 17 | $1,151 |
| Inari Medical, Inc. | 10 | $1,112 |
| Cardiovascular Systems Inc. | 24 | $1,093 |
| W. L. Gore & Associates, Inc. | 5 | $661 |
| Boston Scientific | 15 | $604 |
| Abbott | 10 | $525 |
| Johnson & Johnson(2 entities) | 20 | $502 |
| Tactile Systems Technology Inc | 20 | $312 |
| Cook Medical LLC | 10 | $252 |
| Venclose Inc. | 6 | $204 |
| Koya Medical, Inc. | 3 | $172 |
| Stryker | 1 | $169 |
| Cordis US CORP. | 1 | $150 |
| Biotronik Inc. | 1 | $142 |
| BD | 5 | $141 |
| Baxter Healthcare | 1 | $125 |
| Philips North America LLC | 2 | $87 |
| Organogenesis Inc. | 2 | $75 |
| Bolton Medical Inc | 1 | $71 |
| Vasorum USA Inc. | 1 | $63 |
| Terumo Medical Corporation | 2 | $49 |
| Integra Lifesciences Corporation | 2 | $44 |
| Mimedx Group, Inc. | 1 | $31 |
| Cvrx, Inc. | 1 | $24 |
| Surmodics, Inc. | 1 | $22 |
| Merck | 1 | $20 |
| Merit Medical Systems Inc | 1 | $19 |
| Cardinal Health 200 LLC | 1 | $14 |
| Bayer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alto Abdominal Stent Graft System$12,670
- Abre$8,501
- AFX2 Bifurcated Endograft System$2,207
- HawkOne$2,052
- Indigo$1,889
- Ovation iX Iliac Stent Graft$1,607
- Torus Stent Graft System$1,462
- ENDOCROSS Device$1,462
- ENROUTE Transcarotid Neuroprotection System$1,429
- ENHANCE Transcarotid Peripheral Access Kit$1,203
- ENROUTE Transcarotid Stent System$872
- ENROUTE 0.014 Guidewire$872
- FLOWTRIEVER CATHETER, S$848
- CT THROMBECTOMY SYSTEM KIT$848
- Venclose Maven Catheter$721
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$476
- AFX$475
- Ovation$475
- Diamondback Peripheral$459
- Vascular Lithotripsy$450
How this compares
$77,259 in reported general payments places this provider in the 95th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $14,366 |
| XareltoRivaroxaban | 14 | $13,457 |
| Nitro-BidNitroglycerin | 13 | $526 |
| ClopidogrelClopidogrel Bisulfate | 40 | $316 |
| Cilostazol | 11 | $314 |
| Triamcinolone Acetonide | 13 | $71 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $502 | $13,45714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 519 vascular surgery providers in California.
Other vascular surgery in Newport Beach
- Son DuongFountain Valley$503K
- Venita ChandraPalo Alto$488K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
- Johnathon RolloLos Angeles$337K
- Melissa LojaFairfield$272K
- Jason LeePalo Alto$228K
- John LaneSan Diego$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.